- Home
- BWXT vs PCVX Comparison
BWXT vs PCVX Comparison
Compare BWXT & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWXT
- PCVX
- Stock Information
- Founded
- BWXT 1867
- PCVX 2013
- Country
- BWXT United States
- PCVX United States
- Employees
- BWXT N/A
- PCVX N/A
- Industry
- BWXT
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- BWXT
- PCVX Health Care
- Exchange
- BWXT Nasdaq
- PCVX Nasdaq
- Market Cap
- BWXT 15.4B
- PCVX 4.0B
- IPO Year
- BWXT N/A
- PCVX 2020
- Fundamental
- Price
- BWXT $174.40
- PCVX $31.00
- Analyst Decision
- BWXT Buy
- PCVX Strong Buy
- Analyst Count
- BWXT 10
- PCVX 8
- Target Price
- BWXT $161.95
- PCVX $114.17
- AVG Volume (30 Days)
- BWXT 1.1M
- PCVX 1.4M
- Earning Date
- BWXT 11-03-2025
- PCVX 11-04-2025
- Dividend Yield
- BWXT 0.57%
- PCVX N/A
- EPS Growth
- BWXT 9.94
- PCVX N/A
- EPS
- BWXT 3.21
- PCVX N/A
- Revenue
- BWXT $2,864,520,000.00
- PCVX N/A
- Revenue This Year
- BWXT $17.06
- PCVX N/A
- Revenue Next Year
- BWXT $9.67
- PCVX N/A
- P/E Ratio
- BWXT $54.27
- PCVX N/A
- Revenue Growth
- BWXT 10.13
- PCVX N/A
- 52 Week Low
- BWXT $84.21
- PCVX $27.66
- 52 Week High
- BWXT $189.25
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- BWXT 65.15
- PCVX 43.55
- Support Level
- BWXT $159.87
- PCVX $31.47
- Resistance Level
- BWXT $171.85
- PCVX $33.32
- Average True Range (ATR)
- BWXT 4.00
- PCVX 1.23
- MACD
- BWXT 0.28
- PCVX 0.12
- Stochastic Oscillator
- BWXT 96.92
- PCVX 29.74
About BWXT BWX Technologies Inc.
BWX Technologies Inc is a specialty manufacturer and service provider of nuclear components, operating in two segments: Government Operations and Commercial Operations. The Government Operations segment produces naval nuclear reactors and fuel for the U.S. Naval Nuclear Propulsion Program, while the Commercial Operations segment designs and manufactures commercial nuclear steam generators, heat exchangers, pressure vessels, reactor components, and other auxiliary equipment, including containers for the storage of spent nuclear fuel and other high-level nuclear waste. The majority of the company's revenue comes from Government Operations, with sales principally in the United States, Canada, and other regions.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.